181 related articles for article (PubMed ID: 30384344)
1. Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications.
Zur E
Int J Pharm Compd; 2018; 22(6):446-454. PubMed ID: 30384344
[TBL] [Abstract][Full Text] [Related]
2. The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies.
Balagula Y; Rosen ST; Lacouture ME
J Am Acad Dermatol; 2011 Sep; 65(3):624-635. PubMed ID: 21777992
[TBL] [Abstract][Full Text] [Related]
3. Targeted agents: management of dermatologic toxicities.
Burtness B
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):793-6. PubMed ID: 24853219
[TBL] [Abstract][Full Text] [Related]
4. [Officinal bases and their characteristics].
Hoffmann C
Hautarzt; 2016 Feb; 67(2):190-2. PubMed ID: 26758909
[No Abstract] [Full Text] [Related]
5. [Sense and nonsense of extemporaneous formulations].
Staubach P
Hautarzt; 2014 Mar; 65(3):180-5. PubMed ID: 24424730
[TBL] [Abstract][Full Text] [Related]
6. Compounding is still appropriate in clinical practice.
Thiers BH
Dermatol Clin; 1998 Apr; 16(2):329-30. PubMed ID: 9589206
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and treatment of dermatologic adverse events from epidermal growth factor receptor inhibitors.
Wu PA; Balagula Y; Lacouture ME; Anadkat MJ
Curr Opin Oncol; 2011 Jul; 23(4):343-51. PubMed ID: 21537180
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: A pilot study.
Beamer LC; Grant M
Eur J Oncol Nurs; 2018 Apr; 33():22-27. PubMed ID: 29551173
[TBL] [Abstract][Full Text] [Related]
9. [Management of adverse effects of targeted therapy toxicities in oncology].
Coquan E; Henri P; de Raucourt S; Lireux B; Lamy E; Delcambre C; Sevin E; Dutriaux C; Bouhier-Leporrier K; Gervais R; Joly F
Rev Prat; 2012 Jan; 62(1):17-25. PubMed ID: 22335060
[TBL] [Abstract][Full Text] [Related]
10. Advances in the management of cutaneous toxicities of targeted therapies.
Robert C; Sibaud V; Mateus C; Cherpelis BS
Semin Oncol; 2012 Apr; 39(2):227-40. PubMed ID: 22484194
[TBL] [Abstract][Full Text] [Related]
11. Managing Cutaneous Side Effects From Targeted Molecular Inhibitors for Melanoma and Nonmelanoma Skin Cancer.
Tang N; Ratner D
Dermatol Surg; 2016 Jan; 42 Suppl 1():S40-8. PubMed ID: 26730973
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.
Campanati A; Berardi R; Onofri A; Pierantoni C; Conte I; Giuliodori K; Molinelli E; Marcucci F; Cascinu S; Offidani A
Ann Oncol; 2012 Apr; 23(4):1081-2. PubMed ID: 22457259
[No Abstract] [Full Text] [Related]
13. Effective topical dermatologic therapy.
Cullen SI
Dermatol Clin; 1989 Jan; 7(1):37-42. PubMed ID: 2646048
[TBL] [Abstract][Full Text] [Related]
14. [Dermatologic therapy in pregnancy].
Wohlrab J
Hautarzt; 2010 Dec; 61(12):1046-51. PubMed ID: 21079902
[TBL] [Abstract][Full Text] [Related]
15. [The importance of vehicles in the dermatological therapy].
Tronnier H
Z Haut Geschlechtskr; 1969 Mar; 44(5):155-68. PubMed ID: 5360173
[No Abstract] [Full Text] [Related]
16. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors.
Balagula Y; Garbe C; Myskowski PL; Hauschild A; Rapoport BL; Boers-Doets CB; Lacouture ME
Int J Dermatol; 2011 Feb; 50(2):129-46. PubMed ID: 21244375
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Skin Calcifications with Intra-lesional Injection of Sodium Thiosulphate: A Case Series.
Baumgartner-Nielsen J; Olesen AB
Acta Derm Venereol; 2016 Feb; 96(2):257-8. PubMed ID: 26258586
[No Abstract] [Full Text] [Related]
18. A pilot study of dermofilm in acute radiation-induced desquamative skin reactions.
See A; Wright S; Denham JW
Clin Oncol (R Coll Radiol); 1998; 10(3):182-5. PubMed ID: 9704181
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic adverse events to chemotherapeutic agents, part 1: cytotoxics, epidermal growth factor receptors, multikinase inhibitors, and proteasome inhibitors.
Kyllo RL; Anadkat MJ
Semin Cutan Med Surg; 2014 Mar; 33(1):28-39. PubMed ID: 25037256
[TBL] [Abstract][Full Text] [Related]
20. Herbal preparation extract for skin after radiotherapy treatment. Part One--Preclinical tests.
Skalska-Kamińska A; Woźniak A; Paduch R; Kocjan R; Rejdak R
Acta Pol Pharm; 2014; 71(5):781-8. PubMed ID: 25362806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
